Immunai, BCM developing first-in-human cell therapy for neuroblastoma

Immunai CEO Noam Solomon: “We keep growing Immunai and strengthening the platform.”

Related Keywords

Jerusalem ,Israel General ,Israel ,Leonid Matelitsa ,Andras Heczey ,Leonid Matelista ,Wikimedia Commons ,Baylor College Of Medicine ,Baylor College ,Functional Genomics ,